1. Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real‐world claims data analysis. Issue 3 (March 2017) Authors: Sussman, D.; Yehoshua, A.; Kowalski, J.; Lee, W.; Kish, J.; Chaudhari, S.; Murray, B. Journal: International journal of clinical practice Issue: Volume 71:Issue 3/4(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PB1926: REAL-WORLD ERYTHROPOIESIS-STIMULATING AGENT (ESA) TREATMENT PATTERNS AND OUTCOMES AMONG US PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS). (23rd June 2022) Authors: Mukherjee, S.; Zimmerman Savill, K.; Gajra, A.; Kish, J.; Brown-Bickerstaff, C.; Gentile, D.; Falkenstein, A.; Miller, T.; Laney, J.; McBride, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1805 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗